Global Active Pharmaceutical Ingredient(API) Supply, Demand and Key Producers, 2023-2029
The global Active Pharmaceutical Ingredient(API) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects.
This report studies the global Active Pharmaceutical Ingredient(API) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Active Pharmaceutical Ingredient(API), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Active Pharmaceutical Ingredient(API) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Active Pharmaceutical Ingredient(API) total production and demand, 2018-2029, (K Units)
Global Active Pharmaceutical Ingredient(API) total production value, 2018-2029, (USD Million)
Global Active Pharmaceutical Ingredient(API) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Active Pharmaceutical Ingredient(API) consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Active Pharmaceutical Ingredient(API) domestic production, consumption, key domestic manufacturers and share
Global Active Pharmaceutical Ingredient(API) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Active Pharmaceutical Ingredient(API) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Active Pharmaceutical Ingredient(API) production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Active Pharmaceutical Ingredient(API) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceuticals, Pfizer, Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Novartis, Mylan, Boehringer Ingelheim, Merck&Co. and AbbVie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Active Pharmaceutical Ingredient(API) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Active Pharmaceutical Ingredient(API) Market, By Region:
1. How big is the global Active Pharmaceutical Ingredient(API) market?
2. What is the demand of the global Active Pharmaceutical Ingredient(API) market?
3. What is the year over year growth of the global Active Pharmaceutical Ingredient(API) market?
4. What is the production and production value of the global Active Pharmaceutical Ingredient(API) market?
5. Who are the key producers in the global Active Pharmaceutical Ingredient(API) market?
6. What are the growth factors driving the market demand?
Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects.
This report studies the global Active Pharmaceutical Ingredient(API) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Active Pharmaceutical Ingredient(API), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Active Pharmaceutical Ingredient(API) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Active Pharmaceutical Ingredient(API) total production and demand, 2018-2029, (K Units)
Global Active Pharmaceutical Ingredient(API) total production value, 2018-2029, (USD Million)
Global Active Pharmaceutical Ingredient(API) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Active Pharmaceutical Ingredient(API) consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Active Pharmaceutical Ingredient(API) domestic production, consumption, key domestic manufacturers and share
Global Active Pharmaceutical Ingredient(API) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Active Pharmaceutical Ingredient(API) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Active Pharmaceutical Ingredient(API) production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Active Pharmaceutical Ingredient(API) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceuticals, Pfizer, Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Novartis, Mylan, Boehringer Ingelheim, Merck&Co. and AbbVie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Active Pharmaceutical Ingredient(API) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Active Pharmaceutical Ingredient(API) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Generic API
- Innovative API
- Oncology
- Cardiology
- Cns and Neurology
- Orthopaedic
- Pulmonology
- Gastroenterology
- Nephrology
- Ophthalmology
- Endocrinology
- Teva Pharmaceuticals
- Pfizer
- Aurobindo Pharma
- Sun Pharmaceutical Industries Ltd.
- Novartis
- Mylan
- Boehringer Ingelheim
- Merck&Co.
- AbbVie
- Biocon
- Bristol Myers Squibb
- C.H.Boehringer Sohn AG&Co.KG
- Cipla
- Albemarle Corporation
- Viatris
- Dr. Reddy's Laboratories
1. How big is the global Active Pharmaceutical Ingredient(API) market?
2. What is the demand of the global Active Pharmaceutical Ingredient(API) market?
3. What is the year over year growth of the global Active Pharmaceutical Ingredient(API) market?
4. What is the production and production value of the global Active Pharmaceutical Ingredient(API) market?
5. Who are the key producers in the global Active Pharmaceutical Ingredient(API) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Active Pharmaceutical Ingredient(API) Introduction
1.2 World Active Pharmaceutical Ingredient(API) Supply & Forecast
1.2.1 World Active Pharmaceutical Ingredient(API) Production Value (2018 & 2022 & 2029)
1.2.2 World Active Pharmaceutical Ingredient(API) Production (2018-2029)
1.2.3 World Active Pharmaceutical Ingredient(API) Pricing Trends (2018-2029)
1.3 World Active Pharmaceutical Ingredient(API) Production by Region (Based on Production Site)
1.3.1 World Active Pharmaceutical Ingredient(API) Production Value by Region (2018-2029)
1.3.2 World Active Pharmaceutical Ingredient(API) Production by Region (2018-2029)
1.3.3 World Active Pharmaceutical Ingredient(API) Average Price by Region (2018-2029)
1.3.4 North America Active Pharmaceutical Ingredient(API) Production (2018-2029)
1.3.5 Europe Active Pharmaceutical Ingredient(API) Production (2018-2029)
1.3.6 China Active Pharmaceutical Ingredient(API) Production (2018-2029)
1.3.7 Japan Active Pharmaceutical Ingredient(API) Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Active Pharmaceutical Ingredient(API) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Active Pharmaceutical Ingredient(API) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Active Pharmaceutical Ingredient(API) Demand (2018-2029)
2.2 World Active Pharmaceutical Ingredient(API) Consumption by Region
2.2.1 World Active Pharmaceutical Ingredient(API) Consumption by Region (2018-2023)
2.2.2 World Active Pharmaceutical Ingredient(API) Consumption Forecast by Region (2024-2029)
2.3 United States Active Pharmaceutical Ingredient(API) Consumption (2018-2029)
2.4 China Active Pharmaceutical Ingredient(API) Consumption (2018-2029)
2.5 Europe Active Pharmaceutical Ingredient(API) Consumption (2018-2029)
2.6 Japan Active Pharmaceutical Ingredient(API) Consumption (2018-2029)
2.7 South Korea Active Pharmaceutical Ingredient(API) Consumption (2018-2029)
2.8 ASEAN Active Pharmaceutical Ingredient(API) Consumption (2018-2029)
2.9 India Active Pharmaceutical Ingredient(API) Consumption (2018-2029)
3 WORLD ACTIVE PHARMACEUTICAL INGREDIENT(API) MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Active Pharmaceutical Ingredient(API) Production Value by Manufacturer (2018-2023)
3.2 World Active Pharmaceutical Ingredient(API) Production by Manufacturer (2018-2023)
3.3 World Active Pharmaceutical Ingredient(API) Average Price by Manufacturer (2018-2023)
3.4 Active Pharmaceutical Ingredient(API) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Active Pharmaceutical Ingredient(API) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Active Pharmaceutical Ingredient(API) in 2022
3.5.3 Global Concentration Ratios (CR8) for Active Pharmaceutical Ingredient(API) in 2022
3.6 Active Pharmaceutical Ingredient(API) Market: Overall Company Footprint Analysis
3.6.1 Active Pharmaceutical Ingredient(API) Market: Region Footprint
3.6.2 Active Pharmaceutical Ingredient(API) Market: Company Product Type Footprint
3.6.3 Active Pharmaceutical Ingredient(API) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Active Pharmaceutical Ingredient(API) Production Value Comparison
4.1.1 United States VS China: Active Pharmaceutical Ingredient(API) Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Active Pharmaceutical Ingredient(API) Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Active Pharmaceutical Ingredient(API) Production Comparison
4.2.1 United States VS China: Active Pharmaceutical Ingredient(API) Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Active Pharmaceutical Ingredient(API) Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Active Pharmaceutical Ingredient(API) Consumption Comparison
4.3.1 United States VS China: Active Pharmaceutical Ingredient(API) Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Active Pharmaceutical Ingredient(API) Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Active Pharmaceutical Ingredient(API) Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Active Pharmaceutical Ingredient(API) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value (2018-2023)
4.4.3 United States Based Manufacturers Active Pharmaceutical Ingredient(API) Production (2018-2023)
4.5 China Based Active Pharmaceutical Ingredient(API) Manufacturers and Market Share
4.5.1 China Based Active Pharmaceutical Ingredient(API) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value (2018-2023)
4.5.3 China Based Manufacturers Active Pharmaceutical Ingredient(API) Production (2018-2023)
4.6 Rest of World Based Active Pharmaceutical Ingredient(API) Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Active Pharmaceutical Ingredient(API) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Active Pharmaceutical Ingredient(API) Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Active Pharmaceutical Ingredient(API) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Generic API
5.2.2 Innovative API
5.3 Market Segment by Type
5.3.1 World Active Pharmaceutical Ingredient(API) Production by Type (2018-2029)
5.3.2 World Active Pharmaceutical Ingredient(API) Production Value by Type (2018-2029)
5.3.3 World Active Pharmaceutical Ingredient(API) Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Active Pharmaceutical Ingredient(API) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Cardiology
6.2.3 Cns and Neurology
6.2.4 Orthopaedic
6.2.5 Pulmonology
6.2.6 Gastroenterology
6.2.7 Nephrology
6.2.8 Ophthalmology
6.2.9 Endocrinology
6.3 Market Segment by Application
6.3.1 World Active Pharmaceutical Ingredient(API) Production by Application (2018-2029)
6.3.2 World Active Pharmaceutical Ingredient(API) Production Value by Application (2018-2029)
6.3.3 World Active Pharmaceutical Ingredient(API) Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Teva Pharmaceuticals
7.1.1 Teva Pharmaceuticals Details
7.1.2 Teva Pharmaceuticals Major Business
7.1.3 Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Product and Services
7.1.4 Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Teva Pharmaceuticals Recent Developments/Updates
7.1.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Pfizer
7.2.1 Pfizer Details
7.2.2 Pfizer Major Business
7.2.3 Pfizer Active Pharmaceutical Ingredient(API) Product and Services
7.2.4 Pfizer Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Pfizer Recent Developments/Updates
7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 Aurobindo Pharma
7.3.1 Aurobindo Pharma Details
7.3.2 Aurobindo Pharma Major Business
7.3.3 Aurobindo Pharma Active Pharmaceutical Ingredient(API) Product and Services
7.3.4 Aurobindo Pharma Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Aurobindo Pharma Recent Developments/Updates
7.3.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Sun Pharmaceutical Industries Ltd. Details
7.4.2 Sun Pharmaceutical Industries Ltd. Major Business
7.4.3 Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Product and Services
7.4.4 Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7.4.6 Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis Active Pharmaceutical Ingredient(API) Product and Services
7.5.4 Novartis Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
7.6 Mylan
7.6.1 Mylan Details
7.6.2 Mylan Major Business
7.6.3 Mylan Active Pharmaceutical Ingredient(API) Product and Services
7.6.4 Mylan Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Mylan Recent Developments/Updates
7.6.6 Mylan Competitive Strengths & Weaknesses
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Details
7.7.2 Boehringer Ingelheim Major Business
7.7.3 Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Product and Services
7.7.4 Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Boehringer Ingelheim Recent Developments/Updates
7.7.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.8 Merck&Co.
7.8.1 Merck&Co. Details
7.8.2 Merck&Co. Major Business
7.8.3 Merck&Co. Active Pharmaceutical Ingredient(API) Product and Services
7.8.4 Merck&Co. Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Merck&Co. Recent Developments/Updates
7.8.6 Merck&Co. Competitive Strengths & Weaknesses
7.9 AbbVie
7.9.1 AbbVie Details
7.9.2 AbbVie Major Business
7.9.3 AbbVie Active Pharmaceutical Ingredient(API) Product and Services
7.9.4 AbbVie Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 AbbVie Recent Developments/Updates
7.9.6 AbbVie Competitive Strengths & Weaknesses
7.10 Biocon
7.10.1 Biocon Details
7.10.2 Biocon Major Business
7.10.3 Biocon Active Pharmaceutical Ingredient(API) Product and Services
7.10.4 Biocon Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Biocon Recent Developments/Updates
7.10.6 Biocon Competitive Strengths & Weaknesses
7.11 Bristol Myers Squibb
7.11.1 Bristol Myers Squibb Details
7.11.2 Bristol Myers Squibb Major Business
7.11.3 Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Product and Services
7.11.4 Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Bristol Myers Squibb Recent Developments/Updates
7.11.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.12 C.H.Boehringer Sohn AG&Co.KG
7.12.1 C.H.Boehringer Sohn AG&Co.KG Details
7.12.2 C.H.Boehringer Sohn AG&Co.KG Major Business
7.12.3 C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Product and Services
7.12.4 C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 C.H.Boehringer Sohn AG&Co.KG Recent Developments/Updates
7.12.6 C.H.Boehringer Sohn AG&Co.KG Competitive Strengths & Weaknesses
7.13 Cipla
7.13.1 Cipla Details
7.13.2 Cipla Major Business
7.13.3 Cipla Active Pharmaceutical Ingredient(API) Product and Services
7.13.4 Cipla Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Cipla Recent Developments/Updates
7.13.6 Cipla Competitive Strengths & Weaknesses
7.14 Albemarle Corporation
7.14.1 Albemarle Corporation Details
7.14.2 Albemarle Corporation Major Business
7.14.3 Albemarle Corporation Active Pharmaceutical Ingredient(API) Product and Services
7.14.4 Albemarle Corporation Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Albemarle Corporation Recent Developments/Updates
7.14.6 Albemarle Corporation Competitive Strengths & Weaknesses
7.15 Viatris
7.15.1 Viatris Details
7.15.2 Viatris Major Business
7.15.3 Viatris Active Pharmaceutical Ingredient(API) Product and Services
7.15.4 Viatris Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Viatris Recent Developments/Updates
7.15.6 Viatris Competitive Strengths & Weaknesses
7.16 Dr. Reddy's Laboratories
7.16.1 Dr. Reddy's Laboratories Details
7.16.2 Dr. Reddy's Laboratories Major Business
7.16.3 Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Product and Services
7.16.4 Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.16.6 Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Active Pharmaceutical Ingredient(API) Industry Chain
8.2 Active Pharmaceutical Ingredient(API) Upstream Analysis
8.2.1 Active Pharmaceutical Ingredient(API) Core Raw Materials
8.2.2 Main Manufacturers of Active Pharmaceutical Ingredient(API) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Active Pharmaceutical Ingredient(API) Production Mode
8.6 Active Pharmaceutical Ingredient(API) Procurement Model
8.7 Active Pharmaceutical Ingredient(API) Industry Sales Model and Sales Channels
8.7.1 Active Pharmaceutical Ingredient(API) Sales Model
8.7.2 Active Pharmaceutical Ingredient(API) Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Active Pharmaceutical Ingredient(API) Introduction
1.2 World Active Pharmaceutical Ingredient(API) Supply & Forecast
1.2.1 World Active Pharmaceutical Ingredient(API) Production Value (2018 & 2022 & 2029)
1.2.2 World Active Pharmaceutical Ingredient(API) Production (2018-2029)
1.2.3 World Active Pharmaceutical Ingredient(API) Pricing Trends (2018-2029)
1.3 World Active Pharmaceutical Ingredient(API) Production by Region (Based on Production Site)
1.3.1 World Active Pharmaceutical Ingredient(API) Production Value by Region (2018-2029)
1.3.2 World Active Pharmaceutical Ingredient(API) Production by Region (2018-2029)
1.3.3 World Active Pharmaceutical Ingredient(API) Average Price by Region (2018-2029)
1.3.4 North America Active Pharmaceutical Ingredient(API) Production (2018-2029)
1.3.5 Europe Active Pharmaceutical Ingredient(API) Production (2018-2029)
1.3.6 China Active Pharmaceutical Ingredient(API) Production (2018-2029)
1.3.7 Japan Active Pharmaceutical Ingredient(API) Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Active Pharmaceutical Ingredient(API) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Active Pharmaceutical Ingredient(API) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Active Pharmaceutical Ingredient(API) Demand (2018-2029)
2.2 World Active Pharmaceutical Ingredient(API) Consumption by Region
2.2.1 World Active Pharmaceutical Ingredient(API) Consumption by Region (2018-2023)
2.2.2 World Active Pharmaceutical Ingredient(API) Consumption Forecast by Region (2024-2029)
2.3 United States Active Pharmaceutical Ingredient(API) Consumption (2018-2029)
2.4 China Active Pharmaceutical Ingredient(API) Consumption (2018-2029)
2.5 Europe Active Pharmaceutical Ingredient(API) Consumption (2018-2029)
2.6 Japan Active Pharmaceutical Ingredient(API) Consumption (2018-2029)
2.7 South Korea Active Pharmaceutical Ingredient(API) Consumption (2018-2029)
2.8 ASEAN Active Pharmaceutical Ingredient(API) Consumption (2018-2029)
2.9 India Active Pharmaceutical Ingredient(API) Consumption (2018-2029)
3 WORLD ACTIVE PHARMACEUTICAL INGREDIENT(API) MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Active Pharmaceutical Ingredient(API) Production Value by Manufacturer (2018-2023)
3.2 World Active Pharmaceutical Ingredient(API) Production by Manufacturer (2018-2023)
3.3 World Active Pharmaceutical Ingredient(API) Average Price by Manufacturer (2018-2023)
3.4 Active Pharmaceutical Ingredient(API) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Active Pharmaceutical Ingredient(API) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Active Pharmaceutical Ingredient(API) in 2022
3.5.3 Global Concentration Ratios (CR8) for Active Pharmaceutical Ingredient(API) in 2022
3.6 Active Pharmaceutical Ingredient(API) Market: Overall Company Footprint Analysis
3.6.1 Active Pharmaceutical Ingredient(API) Market: Region Footprint
3.6.2 Active Pharmaceutical Ingredient(API) Market: Company Product Type Footprint
3.6.3 Active Pharmaceutical Ingredient(API) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Active Pharmaceutical Ingredient(API) Production Value Comparison
4.1.1 United States VS China: Active Pharmaceutical Ingredient(API) Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Active Pharmaceutical Ingredient(API) Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Active Pharmaceutical Ingredient(API) Production Comparison
4.2.1 United States VS China: Active Pharmaceutical Ingredient(API) Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Active Pharmaceutical Ingredient(API) Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Active Pharmaceutical Ingredient(API) Consumption Comparison
4.3.1 United States VS China: Active Pharmaceutical Ingredient(API) Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Active Pharmaceutical Ingredient(API) Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Active Pharmaceutical Ingredient(API) Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Active Pharmaceutical Ingredient(API) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value (2018-2023)
4.4.3 United States Based Manufacturers Active Pharmaceutical Ingredient(API) Production (2018-2023)
4.5 China Based Active Pharmaceutical Ingredient(API) Manufacturers and Market Share
4.5.1 China Based Active Pharmaceutical Ingredient(API) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value (2018-2023)
4.5.3 China Based Manufacturers Active Pharmaceutical Ingredient(API) Production (2018-2023)
4.6 Rest of World Based Active Pharmaceutical Ingredient(API) Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Active Pharmaceutical Ingredient(API) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Active Pharmaceutical Ingredient(API) Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Active Pharmaceutical Ingredient(API) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Generic API
5.2.2 Innovative API
5.3 Market Segment by Type
5.3.1 World Active Pharmaceutical Ingredient(API) Production by Type (2018-2029)
5.3.2 World Active Pharmaceutical Ingredient(API) Production Value by Type (2018-2029)
5.3.3 World Active Pharmaceutical Ingredient(API) Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Active Pharmaceutical Ingredient(API) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Cardiology
6.2.3 Cns and Neurology
6.2.4 Orthopaedic
6.2.5 Pulmonology
6.2.6 Gastroenterology
6.2.7 Nephrology
6.2.8 Ophthalmology
6.2.9 Endocrinology
6.3 Market Segment by Application
6.3.1 World Active Pharmaceutical Ingredient(API) Production by Application (2018-2029)
6.3.2 World Active Pharmaceutical Ingredient(API) Production Value by Application (2018-2029)
6.3.3 World Active Pharmaceutical Ingredient(API) Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Teva Pharmaceuticals
7.1.1 Teva Pharmaceuticals Details
7.1.2 Teva Pharmaceuticals Major Business
7.1.3 Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Product and Services
7.1.4 Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Teva Pharmaceuticals Recent Developments/Updates
7.1.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Pfizer
7.2.1 Pfizer Details
7.2.2 Pfizer Major Business
7.2.3 Pfizer Active Pharmaceutical Ingredient(API) Product and Services
7.2.4 Pfizer Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Pfizer Recent Developments/Updates
7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 Aurobindo Pharma
7.3.1 Aurobindo Pharma Details
7.3.2 Aurobindo Pharma Major Business
7.3.3 Aurobindo Pharma Active Pharmaceutical Ingredient(API) Product and Services
7.3.4 Aurobindo Pharma Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Aurobindo Pharma Recent Developments/Updates
7.3.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Sun Pharmaceutical Industries Ltd. Details
7.4.2 Sun Pharmaceutical Industries Ltd. Major Business
7.4.3 Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Product and Services
7.4.4 Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7.4.6 Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis Active Pharmaceutical Ingredient(API) Product and Services
7.5.4 Novartis Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
7.6 Mylan
7.6.1 Mylan Details
7.6.2 Mylan Major Business
7.6.3 Mylan Active Pharmaceutical Ingredient(API) Product and Services
7.6.4 Mylan Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Mylan Recent Developments/Updates
7.6.6 Mylan Competitive Strengths & Weaknesses
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Details
7.7.2 Boehringer Ingelheim Major Business
7.7.3 Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Product and Services
7.7.4 Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Boehringer Ingelheim Recent Developments/Updates
7.7.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.8 Merck&Co.
7.8.1 Merck&Co. Details
7.8.2 Merck&Co. Major Business
7.8.3 Merck&Co. Active Pharmaceutical Ingredient(API) Product and Services
7.8.4 Merck&Co. Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Merck&Co. Recent Developments/Updates
7.8.6 Merck&Co. Competitive Strengths & Weaknesses
7.9 AbbVie
7.9.1 AbbVie Details
7.9.2 AbbVie Major Business
7.9.3 AbbVie Active Pharmaceutical Ingredient(API) Product and Services
7.9.4 AbbVie Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 AbbVie Recent Developments/Updates
7.9.6 AbbVie Competitive Strengths & Weaknesses
7.10 Biocon
7.10.1 Biocon Details
7.10.2 Biocon Major Business
7.10.3 Biocon Active Pharmaceutical Ingredient(API) Product and Services
7.10.4 Biocon Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Biocon Recent Developments/Updates
7.10.6 Biocon Competitive Strengths & Weaknesses
7.11 Bristol Myers Squibb
7.11.1 Bristol Myers Squibb Details
7.11.2 Bristol Myers Squibb Major Business
7.11.3 Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Product and Services
7.11.4 Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Bristol Myers Squibb Recent Developments/Updates
7.11.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.12 C.H.Boehringer Sohn AG&Co.KG
7.12.1 C.H.Boehringer Sohn AG&Co.KG Details
7.12.2 C.H.Boehringer Sohn AG&Co.KG Major Business
7.12.3 C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Product and Services
7.12.4 C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 C.H.Boehringer Sohn AG&Co.KG Recent Developments/Updates
7.12.6 C.H.Boehringer Sohn AG&Co.KG Competitive Strengths & Weaknesses
7.13 Cipla
7.13.1 Cipla Details
7.13.2 Cipla Major Business
7.13.3 Cipla Active Pharmaceutical Ingredient(API) Product and Services
7.13.4 Cipla Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Cipla Recent Developments/Updates
7.13.6 Cipla Competitive Strengths & Weaknesses
7.14 Albemarle Corporation
7.14.1 Albemarle Corporation Details
7.14.2 Albemarle Corporation Major Business
7.14.3 Albemarle Corporation Active Pharmaceutical Ingredient(API) Product and Services
7.14.4 Albemarle Corporation Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Albemarle Corporation Recent Developments/Updates
7.14.6 Albemarle Corporation Competitive Strengths & Weaknesses
7.15 Viatris
7.15.1 Viatris Details
7.15.2 Viatris Major Business
7.15.3 Viatris Active Pharmaceutical Ingredient(API) Product and Services
7.15.4 Viatris Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Viatris Recent Developments/Updates
7.15.6 Viatris Competitive Strengths & Weaknesses
7.16 Dr. Reddy's Laboratories
7.16.1 Dr. Reddy's Laboratories Details
7.16.2 Dr. Reddy's Laboratories Major Business
7.16.3 Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Product and Services
7.16.4 Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.16.6 Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Active Pharmaceutical Ingredient(API) Industry Chain
8.2 Active Pharmaceutical Ingredient(API) Upstream Analysis
8.2.1 Active Pharmaceutical Ingredient(API) Core Raw Materials
8.2.2 Main Manufacturers of Active Pharmaceutical Ingredient(API) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Active Pharmaceutical Ingredient(API) Production Mode
8.6 Active Pharmaceutical Ingredient(API) Procurement Model
8.7 Active Pharmaceutical Ingredient(API) Industry Sales Model and Sales Channels
8.7.1 Active Pharmaceutical Ingredient(API) Sales Model
8.7.2 Active Pharmaceutical Ingredient(API) Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Active Pharmaceutical Ingredient(API) Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Active Pharmaceutical Ingredient(API) Production Value by Region (2018-2023) & (USD Million)
Table 3. World Active Pharmaceutical Ingredient(API) Production Value by Region (2024-2029) & (USD Million)
Table 4. World Active Pharmaceutical Ingredient(API) Production Value Market Share by Region (2018-2023)
Table 5. World Active Pharmaceutical Ingredient(API) Production Value Market Share by Region (2024-2029)
Table 6. World Active Pharmaceutical Ingredient(API) Production by Region (2018-2023) & (K Units)
Table 7. World Active Pharmaceutical Ingredient(API) Production by Region (2024-2029) & (K Units)
Table 8. World Active Pharmaceutical Ingredient(API) Production Market Share by Region (2018-2023)
Table 9. World Active Pharmaceutical Ingredient(API) Production Market Share by Region (2024-2029)
Table 10. World Active Pharmaceutical Ingredient(API) Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Active Pharmaceutical Ingredient(API) Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Active Pharmaceutical Ingredient(API) Major Market Trends
Table 13. World Active Pharmaceutical Ingredient(API) Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Active Pharmaceutical Ingredient(API) Consumption by Region (2018-2023) & (K Units)
Table 15. World Active Pharmaceutical Ingredient(API) Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Active Pharmaceutical Ingredient(API) Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Active Pharmaceutical Ingredient(API) Producers in 2022
Table 18. World Active Pharmaceutical Ingredient(API) Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Active Pharmaceutical Ingredient(API) Producers in 2022
Table 20. World Active Pharmaceutical Ingredient(API) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Active Pharmaceutical Ingredient(API) Company Evaluation Quadrant
Table 22. World Active Pharmaceutical Ingredient(API) Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Active Pharmaceutical Ingredient(API) Production Site of Key Manufacturer
Table 24. Active Pharmaceutical Ingredient(API) Market: Company Product Type Footprint
Table 25. Active Pharmaceutical Ingredient(API) Market: Company Product Application Footprint
Table 26. Active Pharmaceutical Ingredient(API) Competitive Factors
Table 27. Active Pharmaceutical Ingredient(API) New Entrant and Capacity Expansion Plans
Table 28. Active Pharmaceutical Ingredient(API) Mergers & Acquisitions Activity
Table 29. United States VS China Active Pharmaceutical Ingredient(API) Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Active Pharmaceutical Ingredient(API) Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Active Pharmaceutical Ingredient(API) Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Active Pharmaceutical Ingredient(API) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Active Pharmaceutical Ingredient(API) Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Active Pharmaceutical Ingredient(API) Production Market Share (2018-2023)
Table 37. China Based Active Pharmaceutical Ingredient(API) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Active Pharmaceutical Ingredient(API) Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Active Pharmaceutical Ingredient(API) Production Market Share (2018-2023)
Table 42. Rest of World Based Active Pharmaceutical Ingredient(API) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Active Pharmaceutical Ingredient(API) Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Active Pharmaceutical Ingredient(API) Production Market Share (2018-2023)
Table 47. World Active Pharmaceutical Ingredient(API) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Active Pharmaceutical Ingredient(API) Production by Type (2018-2023) & (K Units)
Table 49. World Active Pharmaceutical Ingredient(API) Production by Type (2024-2029) & (K Units)
Table 50. World Active Pharmaceutical Ingredient(API) Production Value by Type (2018-2023) & (USD Million)
Table 51. World Active Pharmaceutical Ingredient(API) Production Value by Type (2024-2029) & (USD Million)
Table 52. World Active Pharmaceutical Ingredient(API) Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Active Pharmaceutical Ingredient(API) Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Active Pharmaceutical Ingredient(API) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Active Pharmaceutical Ingredient(API) Production by Application (2018-2023) & (K Units)
Table 56. World Active Pharmaceutical Ingredient(API) Production by Application (2024-2029) & (K Units)
Table 57. World Active Pharmaceutical Ingredient(API) Production Value by Application (2018-2023) & (USD Million)
Table 58. World Active Pharmaceutical Ingredient(API) Production Value by Application (2024-2029) & (USD Million)
Table 59. World Active Pharmaceutical Ingredient(API) Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Active Pharmaceutical Ingredient(API) Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Teva Pharmaceuticals Major Business
Table 63. Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Product and Services
Table 64. Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Teva Pharmaceuticals Recent Developments/Updates
Table 66. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Major Business
Table 69. Pfizer Active Pharmaceutical Ingredient(API) Product and Services
Table 70. Pfizer Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Pfizer Recent Developments/Updates
Table 72. Pfizer Competitive Strengths & Weaknesses
Table 73. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Aurobindo Pharma Major Business
Table 75. Aurobindo Pharma Active Pharmaceutical Ingredient(API) Product and Services
Table 76. Aurobindo Pharma Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Aurobindo Pharma Recent Developments/Updates
Table 78. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 79. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 80. Sun Pharmaceutical Industries Ltd. Major Business
Table 81. Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Product and Services
Table 82. Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 84. Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 85. Novartis Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Major Business
Table 87. Novartis Active Pharmaceutical Ingredient(API) Product and Services
Table 88. Novartis Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis Recent Developments/Updates
Table 90. Novartis Competitive Strengths & Weaknesses
Table 91. Mylan Basic Information, Manufacturing Base and Competitors
Table 92. Mylan Major Business
Table 93. Mylan Active Pharmaceutical Ingredient(API) Product and Services
Table 94. Mylan Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Mylan Recent Developments/Updates
Table 96. Mylan Competitive Strengths & Weaknesses
Table 97. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 98. Boehringer Ingelheim Major Business
Table 99. Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Product and Services
Table 100. Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Boehringer Ingelheim Recent Developments/Updates
Table 102. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 103. Merck&Co. Basic Information, Manufacturing Base and Competitors
Table 104. Merck&Co. Major Business
Table 105. Merck&Co. Active Pharmaceutical Ingredient(API) Product and Services
Table 106. Merck&Co. Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Merck&Co. Recent Developments/Updates
Table 108. Merck&Co. Competitive Strengths & Weaknesses
Table 109. AbbVie Basic Information, Manufacturing Base and Competitors
Table 110. AbbVie Major Business
Table 111. AbbVie Active Pharmaceutical Ingredient(API) Product and Services
Table 112. AbbVie Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. AbbVie Recent Developments/Updates
Table 114. AbbVie Competitive Strengths & Weaknesses
Table 115. Biocon Basic Information, Manufacturing Base and Competitors
Table 116. Biocon Major Business
Table 117. Biocon Active Pharmaceutical Ingredient(API) Product and Services
Table 118. Biocon Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Biocon Recent Developments/Updates
Table 120. Biocon Competitive Strengths & Weaknesses
Table 121. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 122. Bristol Myers Squibb Major Business
Table 123. Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Product and Services
Table 124. Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Bristol Myers Squibb Recent Developments/Updates
Table 126. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 127. C.H.Boehringer Sohn AG&Co.KG Basic Information, Manufacturing Base and Competitors
Table 128. C.H.Boehringer Sohn AG&Co.KG Major Business
Table 129. C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Product and Services
Table 130. C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. C.H.Boehringer Sohn AG&Co.KG Recent Developments/Updates
Table 132. C.H.Boehringer Sohn AG&Co.KG Competitive Strengths & Weaknesses
Table 133. Cipla Basic Information, Manufacturing Base and Competitors
Table 134. Cipla Major Business
Table 135. Cipla Active Pharmaceutical Ingredient(API) Product and Services
Table 136. Cipla Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Cipla Recent Developments/Updates
Table 138. Cipla Competitive Strengths & Weaknesses
Table 139. Albemarle Corporation Basic Information, Manufacturing Base and Competitors
Table 140. Albemarle Corporation Major Business
Table 141. Albemarle Corporation Active Pharmaceutical Ingredient(API) Product and Services
Table 142. Albemarle Corporation Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Albemarle Corporation Recent Developments/Updates
Table 144. Albemarle Corporation Competitive Strengths & Weaknesses
Table 145. Viatris Basic Information, Manufacturing Base and Competitors
Table 146. Viatris Major Business
Table 147. Viatris Active Pharmaceutical Ingredient(API) Product and Services
Table 148. Viatris Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Viatris Recent Developments/Updates
Table 150. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 151. Dr. Reddy's Laboratories Major Business
Table 152. Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Product and Services
Table 153. Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Active Pharmaceutical Ingredient(API) Upstream (Raw Materials)
Table 155. Active Pharmaceutical Ingredient(API) Typical Customers
Table 156. Active Pharmaceutical Ingredient(API) Typical Distributors
Table 1. World Active Pharmaceutical Ingredient(API) Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Active Pharmaceutical Ingredient(API) Production Value by Region (2018-2023) & (USD Million)
Table 3. World Active Pharmaceutical Ingredient(API) Production Value by Region (2024-2029) & (USD Million)
Table 4. World Active Pharmaceutical Ingredient(API) Production Value Market Share by Region (2018-2023)
Table 5. World Active Pharmaceutical Ingredient(API) Production Value Market Share by Region (2024-2029)
Table 6. World Active Pharmaceutical Ingredient(API) Production by Region (2018-2023) & (K Units)
Table 7. World Active Pharmaceutical Ingredient(API) Production by Region (2024-2029) & (K Units)
Table 8. World Active Pharmaceutical Ingredient(API) Production Market Share by Region (2018-2023)
Table 9. World Active Pharmaceutical Ingredient(API) Production Market Share by Region (2024-2029)
Table 10. World Active Pharmaceutical Ingredient(API) Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Active Pharmaceutical Ingredient(API) Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Active Pharmaceutical Ingredient(API) Major Market Trends
Table 13. World Active Pharmaceutical Ingredient(API) Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Active Pharmaceutical Ingredient(API) Consumption by Region (2018-2023) & (K Units)
Table 15. World Active Pharmaceutical Ingredient(API) Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Active Pharmaceutical Ingredient(API) Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Active Pharmaceutical Ingredient(API) Producers in 2022
Table 18. World Active Pharmaceutical Ingredient(API) Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Active Pharmaceutical Ingredient(API) Producers in 2022
Table 20. World Active Pharmaceutical Ingredient(API) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Active Pharmaceutical Ingredient(API) Company Evaluation Quadrant
Table 22. World Active Pharmaceutical Ingredient(API) Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Active Pharmaceutical Ingredient(API) Production Site of Key Manufacturer
Table 24. Active Pharmaceutical Ingredient(API) Market: Company Product Type Footprint
Table 25. Active Pharmaceutical Ingredient(API) Market: Company Product Application Footprint
Table 26. Active Pharmaceutical Ingredient(API) Competitive Factors
Table 27. Active Pharmaceutical Ingredient(API) New Entrant and Capacity Expansion Plans
Table 28. Active Pharmaceutical Ingredient(API) Mergers & Acquisitions Activity
Table 29. United States VS China Active Pharmaceutical Ingredient(API) Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Active Pharmaceutical Ingredient(API) Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Active Pharmaceutical Ingredient(API) Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Active Pharmaceutical Ingredient(API) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Active Pharmaceutical Ingredient(API) Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Active Pharmaceutical Ingredient(API) Production Market Share (2018-2023)
Table 37. China Based Active Pharmaceutical Ingredient(API) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Active Pharmaceutical Ingredient(API) Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Active Pharmaceutical Ingredient(API) Production Market Share (2018-2023)
Table 42. Rest of World Based Active Pharmaceutical Ingredient(API) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Active Pharmaceutical Ingredient(API) Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Active Pharmaceutical Ingredient(API) Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Active Pharmaceutical Ingredient(API) Production Market Share (2018-2023)
Table 47. World Active Pharmaceutical Ingredient(API) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Active Pharmaceutical Ingredient(API) Production by Type (2018-2023) & (K Units)
Table 49. World Active Pharmaceutical Ingredient(API) Production by Type (2024-2029) & (K Units)
Table 50. World Active Pharmaceutical Ingredient(API) Production Value by Type (2018-2023) & (USD Million)
Table 51. World Active Pharmaceutical Ingredient(API) Production Value by Type (2024-2029) & (USD Million)
Table 52. World Active Pharmaceutical Ingredient(API) Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Active Pharmaceutical Ingredient(API) Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Active Pharmaceutical Ingredient(API) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Active Pharmaceutical Ingredient(API) Production by Application (2018-2023) & (K Units)
Table 56. World Active Pharmaceutical Ingredient(API) Production by Application (2024-2029) & (K Units)
Table 57. World Active Pharmaceutical Ingredient(API) Production Value by Application (2018-2023) & (USD Million)
Table 58. World Active Pharmaceutical Ingredient(API) Production Value by Application (2024-2029) & (USD Million)
Table 59. World Active Pharmaceutical Ingredient(API) Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Active Pharmaceutical Ingredient(API) Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Teva Pharmaceuticals Major Business
Table 63. Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Product and Services
Table 64. Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Teva Pharmaceuticals Recent Developments/Updates
Table 66. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Major Business
Table 69. Pfizer Active Pharmaceutical Ingredient(API) Product and Services
Table 70. Pfizer Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Pfizer Recent Developments/Updates
Table 72. Pfizer Competitive Strengths & Weaknesses
Table 73. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Aurobindo Pharma Major Business
Table 75. Aurobindo Pharma Active Pharmaceutical Ingredient(API) Product and Services
Table 76. Aurobindo Pharma Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Aurobindo Pharma Recent Developments/Updates
Table 78. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 79. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 80. Sun Pharmaceutical Industries Ltd. Major Business
Table 81. Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Product and Services
Table 82. Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 84. Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 85. Novartis Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Major Business
Table 87. Novartis Active Pharmaceutical Ingredient(API) Product and Services
Table 88. Novartis Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis Recent Developments/Updates
Table 90. Novartis Competitive Strengths & Weaknesses
Table 91. Mylan Basic Information, Manufacturing Base and Competitors
Table 92. Mylan Major Business
Table 93. Mylan Active Pharmaceutical Ingredient(API) Product and Services
Table 94. Mylan Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Mylan Recent Developments/Updates
Table 96. Mylan Competitive Strengths & Weaknesses
Table 97. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 98. Boehringer Ingelheim Major Business
Table 99. Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Product and Services
Table 100. Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Boehringer Ingelheim Recent Developments/Updates
Table 102. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 103. Merck&Co. Basic Information, Manufacturing Base and Competitors
Table 104. Merck&Co. Major Business
Table 105. Merck&Co. Active Pharmaceutical Ingredient(API) Product and Services
Table 106. Merck&Co. Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Merck&Co. Recent Developments/Updates
Table 108. Merck&Co. Competitive Strengths & Weaknesses
Table 109. AbbVie Basic Information, Manufacturing Base and Competitors
Table 110. AbbVie Major Business
Table 111. AbbVie Active Pharmaceutical Ingredient(API) Product and Services
Table 112. AbbVie Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. AbbVie Recent Developments/Updates
Table 114. AbbVie Competitive Strengths & Weaknesses
Table 115. Biocon Basic Information, Manufacturing Base and Competitors
Table 116. Biocon Major Business
Table 117. Biocon Active Pharmaceutical Ingredient(API) Product and Services
Table 118. Biocon Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Biocon Recent Developments/Updates
Table 120. Biocon Competitive Strengths & Weaknesses
Table 121. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 122. Bristol Myers Squibb Major Business
Table 123. Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Product and Services
Table 124. Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Bristol Myers Squibb Recent Developments/Updates
Table 126. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 127. C.H.Boehringer Sohn AG&Co.KG Basic Information, Manufacturing Base and Competitors
Table 128. C.H.Boehringer Sohn AG&Co.KG Major Business
Table 129. C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Product and Services
Table 130. C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. C.H.Boehringer Sohn AG&Co.KG Recent Developments/Updates
Table 132. C.H.Boehringer Sohn AG&Co.KG Competitive Strengths & Weaknesses
Table 133. Cipla Basic Information, Manufacturing Base and Competitors
Table 134. Cipla Major Business
Table 135. Cipla Active Pharmaceutical Ingredient(API) Product and Services
Table 136. Cipla Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Cipla Recent Developments/Updates
Table 138. Cipla Competitive Strengths & Weaknesses
Table 139. Albemarle Corporation Basic Information, Manufacturing Base and Competitors
Table 140. Albemarle Corporation Major Business
Table 141. Albemarle Corporation Active Pharmaceutical Ingredient(API) Product and Services
Table 142. Albemarle Corporation Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Albemarle Corporation Recent Developments/Updates
Table 144. Albemarle Corporation Competitive Strengths & Weaknesses
Table 145. Viatris Basic Information, Manufacturing Base and Competitors
Table 146. Viatris Major Business
Table 147. Viatris Active Pharmaceutical Ingredient(API) Product and Services
Table 148. Viatris Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Viatris Recent Developments/Updates
Table 150. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 151. Dr. Reddy's Laboratories Major Business
Table 152. Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Product and Services
Table 153. Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Active Pharmaceutical Ingredient(API) Upstream (Raw Materials)
Table 155. Active Pharmaceutical Ingredient(API) Typical Customers
Table 156. Active Pharmaceutical Ingredient(API) Typical Distributors
LIST OF FIGURES
Figure 1. Active Pharmaceutical Ingredient(API) Picture
Figure 2. World Active Pharmaceutical Ingredient(API) Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Active Pharmaceutical Ingredient(API) Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Active Pharmaceutical Ingredient(API) Production (2018-2029) & (K Units)
Figure 5. World Active Pharmaceutical Ingredient(API) Average Price (2018-2029) & (US$/Unit)
Figure 6. World Active Pharmaceutical Ingredient(API) Production Value Market Share by Region (2018-2029)
Figure 7. World Active Pharmaceutical Ingredient(API) Production Market Share by Region (2018-2029)
Figure 8. North America Active Pharmaceutical Ingredient(API) Production (2018-2029) & (K Units)
Figure 9. Europe Active Pharmaceutical Ingredient(API) Production (2018-2029) & (K Units)
Figure 10. China Active Pharmaceutical Ingredient(API) Production (2018-2029) & (K Units)
Figure 11. Japan Active Pharmaceutical Ingredient(API) Production (2018-2029) & (K Units)
Figure 12. Active Pharmaceutical Ingredient(API) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Active Pharmaceutical Ingredient(API) Consumption (2018-2029) & (K Units)
Figure 15. World Active Pharmaceutical Ingredient(API) Consumption Market Share by Region (2018-2029)
Figure 16. United States Active Pharmaceutical Ingredient(API) Consumption (2018-2029) & (K Units)
Figure 17. China Active Pharmaceutical Ingredient(API) Consumption (2018-2029) & (K Units)
Figure 18. Europe Active Pharmaceutical Ingredient(API) Consumption (2018-2029) & (K Units)
Figure 19. Japan Active Pharmaceutical Ingredient(API) Consumption (2018-2029) & (K Units)
Figure 20. South Korea Active Pharmaceutical Ingredient(API) Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Active Pharmaceutical Ingredient(API) Consumption (2018-2029) & (K Units)
Figure 22. India Active Pharmaceutical Ingredient(API) Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Active Pharmaceutical Ingredient(API) by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Active Pharmaceutical Ingredient(API) Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Active Pharmaceutical Ingredient(API) Markets in 2022
Figure 26. United States VS China: Active Pharmaceutical Ingredient(API) Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Active Pharmaceutical Ingredient(API) Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Active Pharmaceutical Ingredient(API) Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Active Pharmaceutical Ingredient(API) Production Market Share 2022
Figure 30. China Based Manufacturers Active Pharmaceutical Ingredient(API) Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Active Pharmaceutical Ingredient(API) Production Market Share 2022
Figure 32. World Active Pharmaceutical Ingredient(API) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Active Pharmaceutical Ingredient(API) Production Value Market Share by Type in 2022
Figure 34. Generic API
Figure 35. Innovative API
Figure 36. World Active Pharmaceutical Ingredient(API) Production Market Share by Type (2018-2029)
Figure 37. World Active Pharmaceutical Ingredient(API) Production Value Market Share by Type (2018-2029)
Figure 38. World Active Pharmaceutical Ingredient(API) Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Active Pharmaceutical Ingredient(API) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Active Pharmaceutical Ingredient(API) Production Value Market Share by Application in 2022
Figure 41. Oncology
Figure 42. Cardiology
Figure 43. Cns and Neurology
Figure 44. Orthopaedic
Figure 45. Pulmonology
Figure 46. Gastroenterology
Figure 47. Nephrology
Figure 48. Ophthalmology
Figure 49. Endocrinology
Figure 50. World Active Pharmaceutical Ingredient(API) Production Market Share by Application (2018-2029)
Figure 51. World Active Pharmaceutical Ingredient(API) Production Value Market Share by Application (2018-2029)
Figure 52. World Active Pharmaceutical Ingredient(API) Average Price by Application (2018-2029) & (US$/Unit)
Figure 53. Active Pharmaceutical Ingredient(API) Industry Chain
Figure 54. Active Pharmaceutical Ingredient(API) Procurement Model
Figure 55. Active Pharmaceutical Ingredient(API) Sales Model
Figure 56. Active Pharmaceutical Ingredient(API) Sales Channels, Direct Sales, and Distribution
Figure 57. Methodology
Figure 58. Research Process and Data Source
Figure 1. Active Pharmaceutical Ingredient(API) Picture
Figure 2. World Active Pharmaceutical Ingredient(API) Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Active Pharmaceutical Ingredient(API) Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Active Pharmaceutical Ingredient(API) Production (2018-2029) & (K Units)
Figure 5. World Active Pharmaceutical Ingredient(API) Average Price (2018-2029) & (US$/Unit)
Figure 6. World Active Pharmaceutical Ingredient(API) Production Value Market Share by Region (2018-2029)
Figure 7. World Active Pharmaceutical Ingredient(API) Production Market Share by Region (2018-2029)
Figure 8. North America Active Pharmaceutical Ingredient(API) Production (2018-2029) & (K Units)
Figure 9. Europe Active Pharmaceutical Ingredient(API) Production (2018-2029) & (K Units)
Figure 10. China Active Pharmaceutical Ingredient(API) Production (2018-2029) & (K Units)
Figure 11. Japan Active Pharmaceutical Ingredient(API) Production (2018-2029) & (K Units)
Figure 12. Active Pharmaceutical Ingredient(API) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Active Pharmaceutical Ingredient(API) Consumption (2018-2029) & (K Units)
Figure 15. World Active Pharmaceutical Ingredient(API) Consumption Market Share by Region (2018-2029)
Figure 16. United States Active Pharmaceutical Ingredient(API) Consumption (2018-2029) & (K Units)
Figure 17. China Active Pharmaceutical Ingredient(API) Consumption (2018-2029) & (K Units)
Figure 18. Europe Active Pharmaceutical Ingredient(API) Consumption (2018-2029) & (K Units)
Figure 19. Japan Active Pharmaceutical Ingredient(API) Consumption (2018-2029) & (K Units)
Figure 20. South Korea Active Pharmaceutical Ingredient(API) Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Active Pharmaceutical Ingredient(API) Consumption (2018-2029) & (K Units)
Figure 22. India Active Pharmaceutical Ingredient(API) Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Active Pharmaceutical Ingredient(API) by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Active Pharmaceutical Ingredient(API) Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Active Pharmaceutical Ingredient(API) Markets in 2022
Figure 26. United States VS China: Active Pharmaceutical Ingredient(API) Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Active Pharmaceutical Ingredient(API) Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Active Pharmaceutical Ingredient(API) Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Active Pharmaceutical Ingredient(API) Production Market Share 2022
Figure 30. China Based Manufacturers Active Pharmaceutical Ingredient(API) Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Active Pharmaceutical Ingredient(API) Production Market Share 2022
Figure 32. World Active Pharmaceutical Ingredient(API) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Active Pharmaceutical Ingredient(API) Production Value Market Share by Type in 2022
Figure 34. Generic API
Figure 35. Innovative API
Figure 36. World Active Pharmaceutical Ingredient(API) Production Market Share by Type (2018-2029)
Figure 37. World Active Pharmaceutical Ingredient(API) Production Value Market Share by Type (2018-2029)
Figure 38. World Active Pharmaceutical Ingredient(API) Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Active Pharmaceutical Ingredient(API) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Active Pharmaceutical Ingredient(API) Production Value Market Share by Application in 2022
Figure 41. Oncology
Figure 42. Cardiology
Figure 43. Cns and Neurology
Figure 44. Orthopaedic
Figure 45. Pulmonology
Figure 46. Gastroenterology
Figure 47. Nephrology
Figure 48. Ophthalmology
Figure 49. Endocrinology
Figure 50. World Active Pharmaceutical Ingredient(API) Production Market Share by Application (2018-2029)
Figure 51. World Active Pharmaceutical Ingredient(API) Production Value Market Share by Application (2018-2029)
Figure 52. World Active Pharmaceutical Ingredient(API) Average Price by Application (2018-2029) & (US$/Unit)
Figure 53. Active Pharmaceutical Ingredient(API) Industry Chain
Figure 54. Active Pharmaceutical Ingredient(API) Procurement Model
Figure 55. Active Pharmaceutical Ingredient(API) Sales Model
Figure 56. Active Pharmaceutical Ingredient(API) Sales Channels, Direct Sales, and Distribution
Figure 57. Methodology
Figure 58. Research Process and Data Source
